Google+ Facebook Twitter Twitter

Early results for gene editing study

Early, partial results from a historic gene editing study indicate that the treatment may be safe and having at least some of its hoped-for effect.

However, it is too soon to know whether it will ultimately succeed.

The results, announced in September, are from the first human test of gene editing in the body – an attempt to permanently change someone’s DNA to cure a disease.

In this case, they are tackling a genetic disorder called Hunter syndrome that often kills people in their teens. In two patients who got a medium dose of the treatment, urine levels of large sugar compounds that are hallmarks of Hunter syndrome had fallen by half, on average, four months later – a possible sign the treatment is working.

Two others who got a low dose have seen little change in these sugars so far.

However, there’s no way to know yet whether the change are due to the gene editing.

Related Articles

Journal non small cell carcinoma lung science photo library

British Journal of Biomedical Science, Issue 1 2019 – synopsis

Editor Andrew Blann outlines the content of the latest issue, which opens with a synopsis of all the articles published in 2018, with the subtitle “What have we learned?” This review-type article is the subject of a JBL exercise. Notably, six of the eight published articles involve methods in molecular genetics.

World's first total-body scanner

Dr Ramsey Badawi discusses a medical imaging scanner that can capture a 3D picture of the whole human body at once.

Advances in DNA origami

New research describes a method allowing for the automation of DNA origami construction – accelerating and simplifying the process of crafting desired forms.

Diagnosing prostate cancer

Genetic alterations in low-risk prostate cancer diagnosed by needle biopsy can identify men that harbour higher-risk cancer in their prostate glands, according to new research.